Get the Stockscreener App
9.346
2.25%
0.2055
Global X Genomics Biotechnology Etf stock is traded at $9.346, with a volume of 32,595.
It is up +2.25% in the last 24 hours and up +5.79% over the past month.
See More
Previous Close:
$9.1405
Open:
$9.18
24h Volume:
32,595
Relative Volume:
0.78
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.44%
1M Performance:
+5.79%
6M Performance:
-4.92%
1Y Performance:
-17.58%
1-Day Range:
$9.18
$9.43
1-Week Range:
$9.00
$9.43
52-Week Range:
$6.80
$11.68
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Name
Global X Genomics Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Compare GNOM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
9.346 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
318.18 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
645.30 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
648.51 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
252.41 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
571.97 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Stock (GNOM) Latest News
Global X Announces Five ETF Reverse Stock Splits - Eastern Progress
7 Best Biotech ETFs to Buy Now - US News Money
Alnylam Pharmaceuticals Surges 3.79% Intraday – What’s Fueling This Sudden Rally? - AInvest
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Global X Fds Genomics & Biotechnology Etf To Carry Out 1-for-4 Reverse Stock Split On September 2nd, 2025 - 富途牛牛
The Next Big Theme: July 2025 - Seeking Alpha
Stratos Wealth Partners LTD. Buys 2,865 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - 富途牛牛
Middlefield Healthcare Dividend ETF: A Strategic Play on Dividend Income and Sector Resilience - AInvest
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Price Passes Above 200-Day Moving Average of $13.45 - 富途牛牛
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Position Increased by Portland Global Advisors LLC - 富途牛牛
(GNOM) Investment Analysis and Advice - news.stocktradersdaily.com
The long game: ASX ETFs to target amidst an ageing population - The Motley Fool Australia
Global X Genomics & Biotechnology ETF declares semi-annual distribution of $0.0083 - MSN
3 ASX ETFs that could be good value right now - The Motley Fool Australia
Oppenheimer Asset Management Inc. Has $659,000 Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
The Next Big Theme: June 2025 - Global X ETFs
Learn to Evaluate (GNOM) using the Charts - news.stocktradersdaily.com
Gene Therapy Stocks Fall Amid More Turmoil at FDA - Barron's
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Should we bet on a biotech revival? - marketscreener.com
Douglas Dynamics, Inc. (NYSE:PLOW) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Rush Street Interactive (NYSE:RSI) Raised to Strong-Buy at Wall Street Zen - Defense World
15,215 Shares in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Acquired by Citadel Advisors LLC - Defense World
Citadel Advisors LLC Acquires Shares of 10,644 Mastech Digital, Inc. (NYSE:MHH) - Defense World
Citadel Advisors LLC Acquires New Position in Global X Aging Population ETF (NASDAQ:AGNG) - Defense World
8,047 Shares in Innovator U.S. Equity 5 to 15 Buffer ETF – Quarterly (BATS:EALT) Acquired by Citadel Advisors LLC - Defense World
Bank of America Corp DE Grows Stake in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Two Sigma Investments LP Raises Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Bank of America Corp DE Cuts Stock Holdings in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
(GNOM) Trading Advice - news.stocktradersdaily.com
D. E. Shaw & Co. Inc. Purchases New Position in CureVac (NASDAQ:CVAC) - Defense World
BNP Paribas Financial Markets Buys Shares of 23,292 Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $643,000 Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
NETSTREIT Corp. (NYSE:NTST) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Topgolf Callaway Brands Corp. (NYSE:MODG) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 905 Shares of IMAX Co. (NYSE:IMAX) - Defense World
D. E. Shaw & Co. Inc. Purchases New Position in Inter & Co, Inc. (NASDAQ:INTR) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Position in Weis Markets, Inc. (NYSE:WMK) - Defense World
Jane Street Group LLC Invests $547,000 in GS FUT RE & INF EQY ETF (NYSEARCA:GREI) - Defense World
15,605 Shares in AllianzIM U.S. Large Cap Buffer20 Jul ETF (NYSEARCA:JULW) Purchased by Jane Street Group LLC - Defense World
BNP Paribas Financial Markets Sells 4,343 Shares of Metallus Inc. (NYSE:MTUS) - Defense World
Lulu’s Fashion Lounge (NASDAQ:LVLU) Trading Up 0.2% – Here’s Why - Defense World
D. E. Shaw & Co. Inc. Invests $109,000 in Stagwell Inc. (NASDAQ:STGW) - Defense World
D. E. Shaw & Co. Inc. Sells 5,557 Shares of Radiant Logistics, Inc. (NYSEAMERICAN:RLGT) - Defense World
D. E. Shaw & Co. Inc. Boosts Holdings in Kosmos Energy Ltd. (NYSE:KOS) - Defense World
D. E. Shaw & Co. Inc. Sells 356,504 Shares of Marqeta, Inc. (NASDAQ:MQ) - Defense World
Global X Silver Miners ETF (NYSEARCA:SIL) Shares Purchased by BNP Paribas Financial Markets - Defense World
PT Aneka Tambang Tbk (OTCMKTS:PAEKY) Trading 12.5% Higher – Here’s What Happened - Defense World
Orla Mining Ltd. (NYSEAMERICAN:ORLA) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
The Next Big Theme: May 2025 - Seeking Alpha
Hudson Pacific Properties, Inc. (NYSE:HPP) Shares Sold by Northern Trust Corp - Defense World
Global X Genomics Biotechnology Etf Stock (GNOM) Financials Data
There is no financial data for Global X Genomics Biotechnology Etf (GNOM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):